Clinical Trials Logo
  1. Home
  2. Hemorrhage, Surgical
  3. NCT04819945

Clinical Safety and Performance of GATT-Patch in Open Liver Surgery

Hemorrhage, Surgical Clinical Trial

Official title:
A Prospective, Multicenter, Single-arm, Clinical Investigation Evaluating the Safety and Performance of GATT-Patch for Hemostasis During Open Liver Surgery

Clinical Trial Summary

The purpose of this study is to determine the clinical safety and performance of GATT-Patch for management of haemorrhage during elective open liver surgery.

Clinical Trial Description

The GATT-Patch study is a prospective, single arm, multicenter, pre-market, first-in-man clinical investigation, that intents to determine the clinical safety and performance of GATT-Patch for management of haemorrhage during elective open liver surgery. The clinical investigation will be carried out in a maximum of 7 sites in The Netherlands, treating an estimated total of 51 participants. All participants will be thoroughly screened and if found eligible, treated with GATT-Patch during open liver surgery. Participants will be followed for 6 weeks with an additional ultrasound assessment at the 6 week follow up visit. The participant enrolment period is expected to take approximately 6 months, with a total expected duration of the clinical investigation of approximately 8 months. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04819945
Study type Interventional
Source GATT Technologies BV
Contact
Status Completed
Phase N/A
Start date April 1, 2021
Completion date February 7, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05077124 - Safe and Timely Antithrombotic Removal (STAR) Registry
Active, not recruiting NCT06114758 - Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy
Recruiting NCT05900037 - GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery N/A
Completed NCT05397652 - The Aim of This Study is to Examine the Effect of Intravenously Administered Tranexamic Acid (TXA) on the Visual Clarity, Perioperative Hemorrhage, Duration and Early Postoperative Course of Shoulder Arthroscopy in Beach Chair Position. Phase 4
Not yet recruiting NCT02461329 - Comparison of the Effects of Gelatine Versus Balanced Crystalloid Solution for Volume Therapy N/A
Not yet recruiting NCT06357455 - Platelet Count and Function After Usage of Two Different Cell Saver Devices During Liver Transplant Surgery N/A
Completed NCT06038981 - Assessment of the Impact of Perioperative Administration of Tranexamic Acid on Bleeding After Sleeve Gastrectomy N/A
Terminated NCT05093504 - Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D) N/A
Active, not recruiting NCT05385952 - GATT-Patch Versus TachoSil in Liver Surgery N/A
Completed NCT04976530 - Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T) N/A